The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease : Focusing on Molecular Mechanisms and Potential Treatment Strategies
Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can occur in diverse CTDs. Pathologically, CTD-ILD is characterized by various histologic patterns, such as nonspecific interstitial pneumonia, organizing pneumonia, and usual interstitial pneumonia. Abnormal immune system responses have traditionally been instrumental in its pathophysiology, and various changes in immune cells have been described, especially in macrophages. This article first briefly overviews the epidemiology, clinical characteristics, impacts, and histopathologic changes associated with CTD-ILD. Next, it summarizes the roles of various signaling pathways in macrophages or products of macrophages in ILD, helped by insights gained from animal models. In the following sections, this review returns to studies of macrophages in CTD-ILD in humans for an overall picture of the current understanding. Finally, we direct attention to potential therapies targeting macrophages in CTD-ILD in investigation or in clinical trials, as well as the future directions regarding macrophages in the context of CTD-ILD. Although the field of macrophages in CTD-ILD is still in its infancy, several lines of evidence suggest the potential of this area.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
International journal of molecular sciences - 24(2023), 15 vom: 26. Juli |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tseng, Chia-Chun [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Connective tissue disease |
|---|
| Anmerkungen: |
Date Completed 14.08.2023 Date Revised 14.08.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/ijms241511995 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360688756 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360688756 | ||
| 003 | DE-627 | ||
| 005 | 20231226083538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms241511995 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360688756 | ||
| 035 | |a (NLM)37569370 | ||
| 035 | |a (PII)11995 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tseng, Chia-Chun |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Role of Macrophages in Connective Tissue Disease-Associated Interstitial Lung Disease |b Focusing on Molecular Mechanisms and Potential Treatment Strategies |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.08.2023 | ||
| 500 | |a Date Revised 14.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Connective tissue disease-associated interstitial lung disease (CTD-ILD) is a severe manifestation of CTD that leads to significant morbidity and mortality. Clinically, ILD can occur in diverse CTDs. Pathologically, CTD-ILD is characterized by various histologic patterns, such as nonspecific interstitial pneumonia, organizing pneumonia, and usual interstitial pneumonia. Abnormal immune system responses have traditionally been instrumental in its pathophysiology, and various changes in immune cells have been described, especially in macrophages. This article first briefly overviews the epidemiology, clinical characteristics, impacts, and histopathologic changes associated with CTD-ILD. Next, it summarizes the roles of various signaling pathways in macrophages or products of macrophages in ILD, helped by insights gained from animal models. In the following sections, this review returns to studies of macrophages in CTD-ILD in humans for an overall picture of the current understanding. Finally, we direct attention to potential therapies targeting macrophages in CTD-ILD in investigation or in clinical trials, as well as the future directions regarding macrophages in the context of CTD-ILD. Although the field of macrophages in CTD-ILD is still in its infancy, several lines of evidence suggest the potential of this area | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a connective tissue disease | |
| 650 | 4 | |a interstitial lung disease | |
| 650 | 4 | |a macrophage | |
| 650 | 4 | |a systemic sclerosis | |
| 700 | 1 | |a Sung, Ya-Wen |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Kuan-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Pin-Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Yen, Chang-Yi |e verfasserin |4 aut | |
| 700 | 1 | |a Sung, Wan-Yu |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Cheng-Chin |e verfasserin |4 aut | |
| 700 | 1 | |a Ou, Tsan-Teng |e verfasserin |4 aut | |
| 700 | 1 | |a Tsai, Wen-Chan |e verfasserin |4 aut | |
| 700 | 1 | |a Liao, Wei-Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Chung-Jen |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Su-Chen |e verfasserin |4 aut | |
| 700 | 1 | |a Chang, Shun-Jen |e verfasserin |4 aut | |
| 700 | 1 | |a Yen, Jeng-Hsien |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d 2008 |g 24(2023), 15 vom: 26. Juli |w (DE-627)NLM185552161 |x 1422-0067 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:15 |g day:26 |g month:07 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/ijms241511995 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 15 |b 26 |c 07 | ||